首页 | 本学科首页   官方微博 | 高级检索  
     

异基因造血干细胞移植后肺炎的病因分析
引用本文:刘代红,黄晓军,郭乃榄,许兰平,陈欢,韩伟,江倩,刘开彦,陆道培. 异基因造血干细胞移植后肺炎的病因分析[J]. 北京大学学报(医学版), 2005, 37(2): 130-133
作者姓名:刘代红  黄晓军  郭乃榄  许兰平  陈欢  韩伟  江倩  刘开彦  陆道培
作者单位:北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044;北京大学人民医院,北京,100044;北京大学血液病研究所,北京,100044
摘    要:目的:分析异基因造血干细胞移植后肺炎的临床特点和病因谱.方法:总结北京大学血液病研究所1998至2001连续4年中255例异基因造血干细胞移植受者中发生移植后肺炎的资料.结果:66例发生移植后肺炎的患者累计发病72例次,总发病率25.9%;50例患者的移植后肺炎被治愈,占75%.病因分析显示,细/真菌感染性移植后肺炎12例次(16.7%),巨细胞病毒性肺炎22例次(30.6%),特发性肺炎综合征36例次(50.0%).总死亡率为22.7%.发生特发性肺炎综合征的患者较多伴发慢性移植物抗宿主病,免疫抑制剂治疗有效.结论:异基因造血干细胞移植后肺炎是移植后常见的合并症,其病因学包括感染和非感染因素,针对病因的治疗可以改善预后.

关 键 词:造血干细胞移植  手术后并发症  肺炎  移植物抗宿主病
文章编号:1671-167X(2005)02-0130-04
修稿时间:2004-06-21

Analysis of pathogenesis of pneumonia post allogeneic hematopoietic stem cell transplantation
LIU Dai-hong,HUANG Xiao-jun,GUO Nai-lan,Xu Lan-ping,CHEN Huan,HAN Wei,JIANG Qian,LIU Kai-yan,LU Dao-pei. Analysis of pathogenesis of pneumonia post allogeneic hematopoietic stem cell transplantation[J]. Journal of Peking University. Health sciences, 2005, 37(2): 130-133
Authors:LIU Dai-hong  HUANG Xiao-jun  GUO Nai-lan  Xu Lan-ping  CHEN Huan  HAN Wei  JIANG Qian  LIU Kai-yan  LU Dao-pei
Affiliation:Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
Abstract:Objective: To analyse the clinical features and pathogenesis of pneumonia post allogeneic hematopoietic stem cell transplantation (HSCT). Methods: Analysis was made of 255 patients of recipients of allo-HSCT from 1998 to 2001. Results: Seventy-two episodes of pneumonia occurred in 66 patients with the morbidity of 25.9%; 50 (75%) patients were cured. Twelve episodes (16.7%) were caused by mixed infection of bacteria and fungi;22 episodes (30.6%) were caused by cytomegalovirus infection and 36 episodes (50.0%) were classified as idiopathic pneumonia syndrome. The total mortility of pneumonia post allo-HSCT in our institute was 22.7%. The occurrence of chronic graft-versus-host disease was significantly high in idiopathic pneumonia syndrome, in which good response to immune suppressive therapy was observed. Conclusion: Pneumonia post allo-HSCT is a common complication, of which pathogenesis includes infection and non-infection. Its clinical outcome could be improved by specific therapy.
Keywords:Hematopoietic stem cell transplantation  Postoperative complications  Pneumonia  Graft vs host disease
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号